	Factors influencing compliance with cervical cancer screening guidelines among women aged 30 to 49 years in Morocco. Afr J Reprod Health Taouaf J, Loukid M, Lamtali S. PMID: 42819356 [PubMed - indexed for MEDLINE]
	Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications. Front Oncol Incognito D, Ciappina G, Ettore G, Ettore C, Incognito GG, Carroccio P, Esposito E, D'Arienzo A, Barraco C, Donato M, Cianci S, Busà B, Di Mauro G, Berretta M. PMID: 42819173 [PubMed]
	Organoids and AI-integrated models in ovarian cancer research: the future of personalized therapy. Front Oncol Nikam A, Bhutia GT, Sarkar S. PMID: 42819110 [PubMed]
	Applications of virtual reality technology throughout the perioperative period in breast cancer patients: a scoping review. Front Oncol Zheng Y, Yang Q, Lan Y, Zhong C. PMID: 42819093 [PubMed]
	Big Data Analytics Framework for Early Breast Cancer Detection Using Optimized MapReduce and Deep Learning on Large-Scale Mammographic Data. Int J Biomed Imaging Ahmed MM, Hassanien E. PMID: 42819082 [PubMed]
	3D models for cancer-microbe interaction studies via pattern screening: a focus on lung and breast tumoroids. Front Immunol Mandarano M, Sulla A, Vascelli G, Renga G, Floridi C, Pelliccia C, Sidoni A, Oikonomou V, Zelante T. PMID: 42818800 [PubMed - in process]
	Mammography utilization and male breast cancer in BRCA1/2 carriers. medRxiv Davies MY, Tayeb M, Scarrow E, Phun J, Milavsky E, Orr C, Sore R, Lu DY, Symecko H, Ehsan S, Desai H, Hausler R, Wubbenhorst B, Doucette A, Gabriel PE, Nathanson KL, Edmonds CE, Robinson KW, Kelley MJ, Garraway IP, Zullig LL, Bayley EM, Moss HA, Schoen MW, McCarthy AM, Domchek SM, Zhang JQ, Maxwell KN. PMID: 42818478 [PubMed]
	Transformer-Enhanced Deep CNN for Early Detection of Uterine Cancer in Histopathological Images. Microsc Res Tech Lavanya PM, R MM, Baraneedharan P, Rasi D, Sundari KA, Sheema D. PMID: 42817898 [PubMed - as supplied by publisher]
	Serial ctDNA Analysis for Monitoring Molecular Response and Acquired Resistance in Metastatic NSCLC and HR+/HER2-Negative Breast Cancer: A Real-World Study. Cancer Med Knebel FH, Ribeiro MFSA, Linck RDM, Ferreira IF, Masotti C, Saddi R, Sacardo KP, Canedo FSNA, Oliveira LJC, Duarte DC, Asprino PF, Dos Santos EX, Coser EM, Kleftogiannis D, Barber LJ, Gerlinger M, Alessi JVM, Shimada AK, Santini FC, de Souza CE, Feher O, Junior GC, Costa FP, Mano MS, Katz A, Camargo AA, Bettoni F. PMID: 42817873 [PubMed - indexed for MEDLINE]
	Correction: A Phase II Study of Docetaxel and Pembrolizumab plus Interleukin 12 Gene Therapy in Nonmetastatic, Anthracycline-Refractory Triple-Negative Breast Cancer (INTEGRAL). Clin Cancer Res Niravath P, Uzair I, Sun K, Mai H, Guan J, Li M, Deng J, Qian W, Zhou J, Guzman L, Banaglorioso K, Hashmani R, Mathur S, Chang J. PMID: 42817702 [PubMed - in process]
	Active Surveillance for Atypical Ductal Hyperplasia: Are We Ready for Surgical De-escalation? Cancer Prev Res (Phila) Laws A, King TA. PMID: 42817619 [PubMed - indexed for MEDLINE]
	Implementation and evaluation of the Routine Assessment and Integration of Screening for Employment (RAISE) program in adults with metastatic breast cancer. Breast Cancer Res Treat Pinheiro LC, Zeng C, Dorzhieva D, Joseph L, Hamilton Z, Edick K, Mercurio AM, Walker D, Blinder V, Rosenberg SM. PMID: 42816673 [PubMed - indexed for MEDLINE]
	The Best Exercise Modality and Dose to Reduce Cancer-Related Fatigue in Breast Cancer: A Systematic Review with Network and Dose-Response Meta-Analyses. Semin Oncol Nurs Zhang Y, Huang H, Li D, Chen X. PMID: 42816300 [PubMed - as supplied by publisher]
	Elastica-van Gieson-Based Periarterial/Perivenous Invasion and Periductal Invasion as Differential Predictors of Lymph Node Metastasis After Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Special Type. Hum Pathol Mashiba C, Shioya A, Oyama T, Han J, Kumagai M, Shimasaki M, Takata T, Haba Y, Morioka E, Inokuchi M, Yamada S. PMID: 42815785 [PubMed - as supplied by publisher]
	Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis. Radiother Oncol Visani L, Becherini C, Kubeczko M, Caini S, Alkner S, Saura C, Starzer AM, Boersma LJ, de Azambuja E, Harbeck N, Stobart H, Spanic T, Coles CE, Cortés J, Curigliano G, Isacke CM, Jackson SP, Jones CM, Kaidar-Person O, Lambertini M, Marangoni E, Morandi A, Offersen B, Paluch-Shimon S, Rugo H, Livi L, Poortmans P, Meattini I, Florence 2026 International Consensus Investigators. PMID: 42815776 [PubMed - as supplied by publisher]
	Detection Patterns of Breast Cancer Recurrence and Contralateral New Primaries in a Large Integrated Health System. J Natl Compr Canc Netw Duffens AM, Laurent CA, Ergas IJ, Roh JM, Arasu VA, Kushi LH, Liu R. PMID: 42815529 [PubMed - as supplied by publisher]
	Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study. Clin Breast Cancer Douglas A, Moore T, Hughes G, Bacani R, Szymanski B, Moody M, Syed F, Vassar M. PMID: 42815090 [PubMed - as supplied by publisher]
	Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study. Breast LeVee A, Jacob S, Fisch S, Face C, Chengappa M, Chaudhry S, Baclig N, Soliman A, Ruel N, Wong M, Tsai K, Kang I, Kordic A, Huppert L, Quintal L, Melisko M, Majure M, Chien J, Lechner M, Idossa D, Blaes A, McCann K, Rugo HS, Mortimer J. PMID: 42815081 [PubMed - as supplied by publisher]
	Cocreation of a Digital Psychological Intervention to Improve Mental Health Among Survivors of Breast Cancer (SerenApp): Protocol for a Usability and Pilot Randomized Controlled Trial. JMIR Res Protoc Zarcos-Pedrinaci I, Ramos-García V, Padilla-Ruíz M, Rivas-Ruíz F, Baena A, Galán S, Duarte-Díaz A, Perestelo-Pérez L, Álvarez Pérez Y, Valcárcel-Nazco C, Redondo Bautista M, Varela-Moreno E. PMID: 42814999 [PubMed - indexed for MEDLINE]
	Conversational AI in Hereditary Cancer Care: Sociotechnical Study of Responsible Design Requirements. JMIR Hum Factors Lammert D, Lammert J, Hofenbitzer J, Radtke T, Sun Y, Haimerl M, Betz S, Scholl DH, Pfeffer J. PMID: 42814961 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335888

Page 1 of 16795



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy